4//SEC Filing
Lewis Tanya 4
Accession 0001104659-23-071774
CIK 0001737953other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 9:01 PM ET
Size
7.5 KB
Accession
0001104659-23-071774
Insider Transaction Report
Form 4
Lewis Tanya
Director
Transactions
- Sale
Common Stock
2023-06-13$24.10/sh−12,043$290,236→ 136,110 total - Sale
Common Stock
2023-06-13$23.45/sh−817$19,159→ 135,293 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on March 15, 2023, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.59 to $24.57. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.34 to $23.55. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]Following the sales reported on this form 4, the reporting person continues to beneficially own 135,293 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 248,750 shares of the Issuer's common stock, 80,259 of which are exercisable as of the date hereof.
Documents
Issuer
Replimune Group, Inc.
CIK 0001737953
Entity typeother
Related Parties
1- filerCIK 0001451038
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 9:01 PM ET
- Size
- 7.5 KB